Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Global antimicrobial use has grown, WOAH reveals
WOAH believes the trend could slow progress against AMR.

It is the first increase after consecutive years of decrease.

A new report published by the World Organisation for Animal Health (WOAH) has revealed a global increase in antimicrobial use within the animal sector.

The statistics, collected between 2019 and 2021, showed that there had been a two per cent increase in antimicrobial use in animals.

The concerning increase follows several consecutive years of significantly decreasing antimicrobial usage. WOAH believes that this trend could lead to progress against antimicrobial resistance (AMR) slowing down in the animal sector.

AMR is currently considered to be a major concern for humans, animals and the environment. When antimicrobials are misused or overused diseases can develop a resistance to their effects, meaning the diseases are much harder to manage.

Economic reports from the Global Leaders Group (GLG) predict a loss of 1.8 years of life expectancy worldwide by 2035, as a result of AMR.

AMR can be a natural phenomenon, however it is greatly advanced by the irresponsible use of antimicrobials.

WOAH suggests that efficient monitoring could lead to informed decisions on combatting AMR. It has been observing antimicrobial use in animals since 2015, as it builds its own strategy.

One of the four key actions that WOAH considers vital to its strategy is the implementation of preventative measures.

For example, it suggests that vaccines could reduce the need for antimicrobials. If they can be made available, vaccines can prevent diseases which may otherwise need antimicrobial treatment.

Despite this, WOAH says that only six cents for every ten dollars were allocated to the research and development of animal health vaccines between 2017 and 2024.

Furthermore, WOAH stated that the use of antimicrobials for growth promotion in animals still remains a contributor to AMR.

Although progress has been made in reducing this practice, it was still reported by 20 per cent of WOAH’s members. Eleven per cent were using critically important antimicrobials, such as colistin, to promote the productivity of their animals.

WOAH’s findings were presented at the ninth meeting of the GLG on AMR in Sweden. It has called for more support for the animal health sector, as it combats the threat of AMR.

Monique Eloit, WOAH director general, said: “The animal health sector plays a pivotal role in the efforts to curb AMR by promoting a more responsible use of antimicrobials.

“Therefore, it has to be adequately supported to help accelerate the response to this still growing threat.”

The full report can be found here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.